Effect of alternate-week versus continuous dexamethasone scheduling on the risk of osteonecrosis in paediatric patients with acute lymphoblastic leukaemia: results from the CCG-1961 randomised cohort trial.

Autor: Mattano LA Jr (AUTHOR), Devidas M (AUTHOR), Nachman JB (AUTHOR), Sather HN (AUTHOR), Hunger SP (AUTHOR), Steinherz PG (AUTHOR), Gaynon PS (AUTHOR), Seibel NL (AUTHOR), Children's Oncology Group (CORPORATE AUTHOR), Mattano, Leonard A Jr¹ (AUTHOR), Devidas, Meenakshi (AUTHOR), Nachman, James B (AUTHOR), Sather, Harland N (AUTHOR), Hunger, Stephen P (AUTHOR), Steinherz, Peter G (AUTHOR), Gaynon, Paul S (AUTHOR), Seibel, Nita L (AUTHOR)

Publikováno v: Lancet Oncology. Sep2012, Vol. 13 Issue 9, p906-915. 10p.

Multidisciplinary rounds. An adolescent with acute lymphoblastic leukemia.

Autor: Cremer L (AUTHOR), Eilers J (AUTHOR), Kinney-Wieland S (AUTHOR), Nuss S (AUTHOR), Engbrecht LM (AUTHOR), Mattano LA Jr. (AUTHOR), Mora-Pagkalinawan M (AUTHOR), Knobf MT (EDITOR), Hilderley LJ (EDITOR), Iwamoto RR (EDITOR)

Publikováno v: Cancer Practice. Jan2002, Vol. 10 Issue 1, p6-10. 5p.

Racial and ethnic disparities in childhood and young adult acute lymphocytic leukaemia: secondary analyses of eight Children's Oncology Group cohort trials.

Autor: Gupta S; Cancer Research Program, ICES, Toronto, ON, Canada; Institute for Health Policy, Evaluation and Management and Faculty of Medicine, University of Toronto, Toronto, ON, Canada; Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, ON, Canada. Electronic address: sumit.gupta@sickkids.ca., Dai Y; Biostatistics, University of Florida, Gainesville, FL, USA., Chen Z; Biostatistics, University of Florida, Gainesville, FL, USA., Winestone LE; Department of Pediatrics, Benioff Children's Hospital and the Helen Diller Comprehensive Cancer Centre, University of California, San Francisco, San Francisco, CA, USA., Teachey DT; Cellular Therapy and Transplant Section and Cancer Immunotherapy Program, Children's Hospital of Philadelphia, Philadelphia, PA, USA; Division of Oncology, Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Bona K; Division of Population Sciences, Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Aplenc R; Cellular Therapy and Transplant Section and Cancer Immunotherapy Program, Children's Hospital of Philadelphia, Philadelphia, PA, USA; Division of Oncology, Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Rabin KR; Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA., Zweidler-McKay P; Department of Pediatrics Research, The University of Texas MD Anderson Cancer Centre, Houston, TX, USA; University of Texas MD Anderson UT Health Graduate School of Biomedical Sciences, Houston, TX, USA; ImmunoGen, Waltham, MA, USA., Carroll AJ; Department of Genetics, University of Alabama at Birmingham, Birmingham, AL, USA., Heerema NA; Department of Pathology, The Ohio State University Wexner School of Medicine, Columbus, OH, USA., Gastier-Foster J; Department of Pathology and Laboratory Medicine, Nationwide Children's Hospital, Columbus, OH, USA; Department of Pediatrics, Ohio State University School of Medicine, Columbus, OH, USA., Borowitz MJ; Johns Hopkins University, Baltimore, MD, USA., Wood BL; Department of Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA, USA., Maloney KW; Department of Pediatrics, University of Colorado and Children's Hospital Colorado, Aurora, CO, USA., Mattano LA Jr; HARP Pharma Consulting, Mystic, CT, USA., Larsen EC; Department of Pediatrics, Maine Children's Cancer Program, Scarborough, ME, USA., Angiolillo AL; Division of Oncology, Centre for Cancer and Blood Disorders, Children's National Hospital, Washington, DC, USA., Burke MJ; Division of Pediatric Hematology-Oncology, Medical College of Wisconsin, Milwaukee, WI, USA., Salzer WL; US Army Medical Research and Materiel Command, Fort Detrick, Frederick, MD, USA., Winter SS; Children's Hospitals and Clinics of Minnesota, Minneapolis, MN, USA., Brown PA; Johns Hopkins University, Baltimore, MD, USA., Guest EM; Genomic Medicine Centre, Children's Mercy Hospital, Kansas City, MO, USA., Dunsmore KP; Department of Pediatrics, University of Virginia School of Medicine, Charlottesville, VA, USA., Kairalla JA; Biostatistics, University of Florida, Gainesville, FL, USA., Winick NJ; Simmons Cancer Center and Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX, USA., Carroll WL; Department of Pediatrics, NYU Langone Health, New York City, NY, USA., Raetz EA; Department of Pediatrics, NYU Langone Health, New York City, NY, USA., Hunger SP; Division of Oncology, Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Loh ML; Department of Pediatrics, Benioff Children's Hospital and the Helen Diller Comprehensive Cancer Centre, University of California, San Francisco, San Francisco, CA, USA., Devidas M; Department of Global Pediatric Medicine, St Jude Children's Research Hospital, Memphis, TN, USA.

Publikováno v: The Lancet. Haematology [Lancet Haematol] 2023 Feb; Vol. 10 (2), pp. e129-e141.

Favorable Trisomies and ETV6-RUNX1 Predict Cure in Low-Risk B-Cell Acute Lymphoblastic Leukemia: Results From Children's Oncology Group Trial AALL0331.

Autor: Mattano LA Jr; HARP Pharma Consulting, Mystic, CT., Devidas M; Department of Global Pediatric Medicine, St Jude Children's Research Hospital, Memphis, TN., Maloney KW; Department of Pediatrics, University of Colorado and Children's Hospital Colorado, Aurora, CO., Wang C; Department of Biostatistics, Colleges of Medicine, Public Health, and Health Professions, University of Florida, Gainesville, FL., Friedmann AM; Department of Pediatrics, Massachusetts General Hospital Cancer Center, Boston, MA., Buckley P; Department of Pathology, Duke University Medical Center, Durham, NC., Borowitz MJ; Department of Pathology, Johns Hopkins University, Baltimore, MD., Carroll AJ; Department of Genetics, Children's Hospital of Alabama, Birmingham, AL., Gastier-Foster JM; Department of Pathology and Laboratory Medicine, Nationwide Children's Hospital, Ohio State University College of Medicine, Columbus, OH.; Departments of Pathology and Pediatrics, Ohio State University College of Medicine, Columbus, OH., Heerema NA; Department of Pathology, Wexner Medical Center, Ohio State University, Columbus, OH., Kadan-Lottick NS; Department of Pediatrics, Yale University and Yale Cancer Center, New Haven, CT., Matloub YH; Case Western Reserve University School of Medicine, Cleveland, OH., Marshall DT; Department of Radiation Oncology, Medical University of South Carolina, Charleston, SC., Stork LC; Department of Pediatrics, Oregon Health and Science University, Portland, OR., Loh ML; Department of Pediatrics, Benioff Children's Hospital and the Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA., Raetz EA; Perlmutter Cancer Center and Department of Pediatrics, NYU Langone Medical Center, New York, NY., Wood BL; Departments of Pathology and Medicine, University of Washington, Seattle, WA., Hunger SP; Department of Pediatrics and The Center for Childhood Cancer Research, Children's Hospital of Philadelphia and the Perelman School of Medicine at The University of Philadelphia, Philadelphia, PA., Carroll WL; Perlmutter Cancer Center and Department of Pediatrics, NYU Langone Medical Center, New York, NY., Winick NJ; Department of Pediatrics, UT Southwestern, Simmons Cancer Center, Dallas, TX.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2021 May 10; Vol. 39 (14), pp. 1540-1552. Date of Electronic Publication: 2021 Mar 19.

Impact of corticosteroid pretreatment in pediatric patients with newly diagnosed B-lymphoblastic leukemia: a report from the Children's Oncology Group.

Autor: Raetz EA; Department of Pediatrics and Perlmutter Cancer Center, NYU Langone Health, New York, NY elizabeth.raetz@nyulangone.org., Loh ML; Department of Pediatrics, Benioff Children's Hospital, and the Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA., Devidas M; Department of Biostatistics, Colleges of Medicine, Public Health and Health Professions, University of Florida, Gainesville, FL., Maloney K; Department of Pediatrics University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, CO., Mattano LA Jr; HARP Pharma Consulting, Mystic, CT., Larsen E; Department of Pediatrics, Maine Children's Cancer Program, Scarborough, ME., Carroll A; Department of Genetics, University of Alabama at Birmingham, Birmingham, AL., Heerema NA; Department of Pathology, Wexner Medical Center, Ohio State University, Columbus, OH., Gastier-Foster JM; Institute for Genomic Medicine, Nationwide Children's Hospital and Departments of Pathology and Pediatrics, Ohio State University College of Medicine, Columbus, OH., Wood B; Departments of Pathology and Medicine, University of Washington, Seattle, WA., Borowitz MJ; Departments of Pathology and Oncology, Johns Hopkins Medical Institutions, Baltimore, MD., Winick N; Departments of Pediatrics, UT Southwestern, Dallas, TX., Hunger SP; Department of Pediatrics and the Center for Childhood Cancer Research, Children's Hospital of Philadelphia and Perelman School of Medicine at the University of Pennsylvania, PA, USA., Carroll WL; Department of Pediatrics and Perlmutter Cancer Center, NYU Langone Health, New York, NY.

Publikováno v: Haematologica [Haematologica] 2019 Nov; Vol. 104 (11), pp. e517-e520. Date of Electronic Publication: 2019 Apr 19.